112 related articles for article (PubMed ID: 2835137)
1. L-656,224 (7-chloro-2-[(4-methoxyphenyl)methyl]-3- methyl-5-propyl-4-benzofuranol): a novel, selective, orally active 5-lipoxygenase inhibitor.
Belanger P; Maycock A; Guindon Y; Bach T; Dollob AL; Dufresne C; Ford-Hutchinson AW; Gale PH; Hopple S; Lau CK
Can J Physiol Pharmacol; 1987 Dec; 65(12):2441-8. PubMed ID: 2835137
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationships of a novel class of 5-lipoxygenase inhibitors. 2-(Phenylmethyl)-4-hydroxy-3,5-dialkylbenzofurans: the development of L-656,224.
Lau CK; Bélanger PC; Scheigetz J; Dufresne C; Williams HW; Maycock AL; Guindon Y; Bach T; Dallob AL; Denis D
J Med Chem; 1989 Jun; 32(6):1190-7. PubMed ID: 2542553
[TBL] [Abstract][Full Text] [Related]
3. 6,7,4'-Trihydroxyisoflavan: a potent and selective inhibitor of 5-lipoxygenase in human and porcine peripheral blood leukocytes.
Kuhl P; Shiloh R; Jha H; Murawski U; Zilliken F
Prostaglandins; 1984 Dec; 28(6):783-804. PubMed ID: 6441190
[TBL] [Abstract][Full Text] [Related]
4. L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2 - dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor.
Gillard J; Ford-Hutchinson AW; Chan C; Charleson S; Denis D; Foster A; Fortin R; Leger S; McFarlane CS; Morton H
Can J Physiol Pharmacol; 1989 May; 67(5):456-64. PubMed ID: 2548691
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and biological activities of 2,3-dihydro-6-[3-(2-hydroxymethyl)phenyl-2-propenyl]-5-benzofuranol (L-651,896), a novel topical anti-inflammatory agent.
Bonney RJ; Davies P; Dougherty H; Egan RW; Gale PH; Chang M; Hammond M; Jensen N; MacDonald J; Thompson K
Biochem Pharmacol; 1987 Nov; 36(22):3885-91. PubMed ID: 3120729
[TBL] [Abstract][Full Text] [Related]
6. Naphthalenic lignan lactones as selective, nonredox 5-lipoxygenase inhibitors. Synthesis and biological activity of (methoxyalkyl)thiazole and methoxytetrahydropyran hybrids.
Ducharme Y; Brideau C; Dubé D; Chan CC; Falgueyret JP; Gillard JW; Guay J; Hutchinson JH; McFarlane CS; Riendeau D
J Med Chem; 1994 Feb; 37(4):512-8. PubMed ID: 8120869
[TBL] [Abstract][Full Text] [Related]
7. WY-50,295 tromethamine, a novel, orally active 5-lipoxygenase inhibitor: biochemical characterization and antiallergic activity.
Grimes D; Sturm RJ; Marinari LR; Carlson RP; Berkenkopf JW; Musser JH; Kreft AF; Weichman BM
Eur J Pharmacol; 1993 May; 236(2):217-28. PubMed ID: 8391458
[TBL] [Abstract][Full Text] [Related]
8. Effect of structure on potency and selectivity in 2,6-disubstituted 4-(2-arylethenyl)phenol lipoxygenase inhibitors.
Lazer ES; Wong HC; Wegner CD; Graham AG; Farina PR
J Med Chem; 1990 Jul; 33(7):1892-8. PubMed ID: 2113949
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology of MK-0591 (3-[1-(4-chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-yl-methoxy)- indol-2-yl]-2,2-dimethyl propanoic acid), a potent, orally active leukotriene biosynthesis inhibitor.
Brideau C; Chan C; Charleson S; Denis D; Evans JF; Ford-Hutchinson AW; Fortin R; Gillard JW; Guay J; Guévremont D
Can J Physiol Pharmacol; 1992 Jun; 70(6):799-807. PubMed ID: 1330258
[TBL] [Abstract][Full Text] [Related]
10. Development of 2,3-dihydro-6-(3-phenoxypropyl)-2-(2-phenylethyl)-5-benzofuranol (L-670,630) as a potent and orally active inhibitor of 5-lipoxygenase.
Lau CK; Bélanger PC; Dufresne C; Scheigetz J; Therien M; Fitzsimmons B; Young RN; Ford-Hutchinson AW; Riendeau D; Denis D
J Med Chem; 1992 Apr; 35(7):1299-318. PubMed ID: 1313879
[TBL] [Abstract][Full Text] [Related]
11. Characterization of CGS 8515 as a selective 5-lipoxygenase inhibitor using in vitro and in vivo models.
Ku EC; Raychaudhuri A; Ghai G; Kimble EF; Lee WH; Colombo C; Dotson R; Oglesby TD; Wasley JW
Biochim Biophys Acta; 1988 Apr; 959(3):332-42. PubMed ID: 2833314
[TBL] [Abstract][Full Text] [Related]
12. Effects of a 5-lipoxygenase inhibitor (L-651,392) on primary and late pulmonary responses to ascaris antigen in the squirrel monkey.
McFarlane CS; Hamel R; Ford-Hutchinson AW
Agents Actions; 1987 Oct; 22(1-2):63-8. PubMed ID: 3687598
[TBL] [Abstract][Full Text] [Related]
13. Flavonoids: potent inhibitors of arachidonate 5-lipoxygenase.
Yoshimoto T; Furukawa M; Yamamoto S; Horie T; Watanabe-Kohno S
Biochem Biophys Res Commun; 1983 Oct; 116(2):612-8. PubMed ID: 6418162
[TBL] [Abstract][Full Text] [Related]
14. Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.
Chan CC; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Ford-Hutchinson AW; Forrest MJ; Gauthier JY; Gordon R; Gresser M; Guay J; Kargman S; Kennedy B; Leblanc Y; Leger S; Mancini J; O'Neill GP; Ouellet M; Patrick D; Percival MD; Perrier H; Prasit P; Rodger I
J Pharmacol Exp Ther; 1999 Aug; 290(2):551-60. PubMed ID: 10411562
[TBL] [Abstract][Full Text] [Related]
15. Affinities of various mammalian arachidonate lipoxygenases and cyclooxygenases for molecular oxygen as substrate.
Juránek I; Suzuki H; Yamamoto S
Biochim Biophys Acta; 1999 Jan; 1436(3):509-18. PubMed ID: 9989280
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
17. Preferential inhibition of 5-lipoxygenase activity by manoalide.
De Vries GW; Amdahl L; Mobasser A; Wenzel M; Wheeler LA
Biochem Pharmacol; 1988 Aug; 37(15):2899-905. PubMed ID: 2840081
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human leukocyte 5-lipoxygenase by a 4-hydroxybenzofuran, L-656,224. Evidence for enzyme reduction and inhibitor degradation.
Rouzer CA; Riendeau D; Falgueyret JP; Lau CK; Gresser MJ
Biochem Pharmacol; 1991 May; 41(9):1365-73. PubMed ID: 2018568
[TBL] [Abstract][Full Text] [Related]
19. 2,3-Dihydro-5-benzofuranols as antioxidant-based inhibitors of leukotriene biosynthesis.
Hammond ML; Kopka IE; Zambias RA; Caldwell CG; Boger J; Baker F; Bach T; Luell S; MacIntyre DE
J Med Chem; 1989 May; 32(5):1006-20. PubMed ID: 2709371
[TBL] [Abstract][Full Text] [Related]
20. Disulfiram is a potent inhibitor of rat 5-lipoxygenase activity.
Choo LY; Riendeau D
Can J Physiol Pharmacol; 1987 Dec; 65(12):2503-6. PubMed ID: 3449208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
